Characterization of Plasmodium Falciparum Resistance Genes to Common Antimalarial Drugs in Semi-urban Areas of Burkina Faso

期刊论文
发表日期：

2024年3月13日

查看全文

Adama Zida,
Chanolle Tchekounou,
Issiaka Soulama,
Cheikna Zongo,
Salif Sombié,
Seni Nikiema,
Nassandba J. Yanogo,
Salam Sawadogo,
Farida C. A. Kaboré,
Oumou A. Z. D. Zoure,
Haffsatou Sawadogo,
Patindoilba M. Sawadogo,
Yssimini N. G. Tibiri,
Kiswendsida T. Guiguemde,
Raissa P. Ily,
Rasmata Ouedraogo-Traoré,
Youssoufou Ouedraogo,
Aly Savadogo

摘要

Introduction

Malaria still remains the most frequent parasitic disease on the world with, in 2022, 249 million cases and 608,000 deaths worldwide. Malaria control is compromised by the spread of the parasite’s resistance to available antimalarials. The objective of our study is to characterize the Plasmodium falciparum resistance genes to common antimalarial drugs in semi-urban areas of Burkina Faso.

Materials and Methods

This is a prospective cross-sectional study whose collection took place from June to October 2021 and from June to October 2022 in five health facilities in Burkina Faso. The molecular analysis based on PCR–RFLP took place from January to June 2023 at Centre National de Recherche et de Formation (CNRFP) to determine resistance genes such as Pfcrt, Pfmdr1, Pfdhps, and Pfdhfr.

Results

A total of 150 samples were analyzed giving a prevalence of 46.67, 1.33, 0.67, 20, 82, and 4.67%, for Pfcrt 76 T, Pfmdr1 86Y, Pfdhps 437G, Pfdhfr 51I, Pfdhfr 59R, and Pfdhfr 108N mutations, respectively. There are no mutations observed Pfdhps 540E and Pfdhfr 164L positions. However, mutation on Pfdhfr 59R position was the most common. In addition, triple mutation (Pfdhps 437G + Pfdhfr 59R + Pfdhfr 108N) was found with a low frequency which is 0.67%.

Conclusion

Surveillance of Plasmodium falciparum resistance markers to antimalarial drugs, remains one of the priorities in the context of the control or malaria elimination.